ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vaccibody signs agreement with Genentech for individualised neoantigen cancer vaccines
October 10, 2020Biopharmaceutical company Vaccibody has signed an exclusive worldwide license and collaboration agreement with Genentech for the development and commercialisation of DNA-based individualised neoantigen cancer vaccines. -
Vaccibody, Nektar Announce First Patient Dosed in Study for Personalized Neoantigen Cancer Vaccine
August 17, 2020Vaccibody AS and Nektar Therapeutics announced the first patient has been dosed in the combination therapy of the Phase 1/2a study ... -
Vaccibody Moving Forward with Cancer Neoantigen Vaccine Trial
April 19, 2018PharmaJet announced Vaccibody AS has received approval to start their cancer neoantigen trial using the PharmaJet Stratis needle-free injection system.
Pharma Sources Insight January 2025
